25th Nov 2020 14:29
25 November 2020
SourceBio International plc
("SourceBio", the "Company" or the "Group")
Director/PDMR Shareholding
SourceBio International plc has been notified that on 25 November 2020, Harwood Capital LLP acquired 36,776 ordinary shares of 0.15 pence each in the Company ("Ordinary Shares"). Christopher Mills, Non-Executive Director of the Company is Chief Executive of Harwood Capital LLP.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
|
Harwood Capital LLP as investment manager | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Christopher Mills is a non-executive director of the issuer and Chief Executive of the investment manager | |||
b)
| Initial notification /Amendment
| Initial Notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| SourceBio International Plc | |||
b)
| LEI
| 213800KY4C9WU7WBW518
| |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of £0.0015 each | |||
Identification code | GB00BKSB1674
| ||||
b)
| Nature of the transaction
| Share purchase | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
183.136p | 36,776 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A - Single trade | ||||
- Price | N/A - Single trade | ||||
e)
| Date of the transaction
| 24 November 2020 | |||
f)
| Place of the transaction
| London Stock Exchange | |||
Related Shares:
SBI.L